JP2016501261A5 - - Google Patents

Download PDF

Info

Publication number
JP2016501261A5
JP2016501261A5 JP2015546419A JP2015546419A JP2016501261A5 JP 2016501261 A5 JP2016501261 A5 JP 2016501261A5 JP 2015546419 A JP2015546419 A JP 2015546419A JP 2015546419 A JP2015546419 A JP 2015546419A JP 2016501261 A5 JP2016501261 A5 JP 2016501261A5
Authority
JP
Japan
Prior art keywords
mal
ppi
iii
dendrimer
maltotriose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015546419A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016501261A (ja
Filing date
Publication date
Priority claimed from PL401936A external-priority patent/PL234888B1/pl
Application filed filed Critical
Publication of JP2016501261A publication Critical patent/JP2016501261A/ja
Publication of JP2016501261A5 publication Critical patent/JP2016501261A5/ja
Pending legal-status Critical Current

Links

JP2015546419A 2012-12-06 2013-12-06 マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−OS−Mal−IIIの使用 Pending JP2016501261A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL401936A PL234888B1 (pl) 2012-12-06 2012-12-06 Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-OS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej
PLP-401936 2012-12-06
PCT/PL2013/000163 WO2014088435A1 (en) 2012-12-06 2013-12-06 Application of maltotriose-coated 4th generation polypropyleneimine dendrimer ppi-g4-os-mal-iii

Publications (2)

Publication Number Publication Date
JP2016501261A JP2016501261A (ja) 2016-01-18
JP2016501261A5 true JP2016501261A5 (cg-RX-API-DMAC10.html) 2017-01-26

Family

ID=49955472

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015546419A Pending JP2016501261A (ja) 2012-12-06 2013-12-06 マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−OS−Mal−IIIの使用

Country Status (9)

Country Link
US (1) US9877985B2 (cg-RX-API-DMAC10.html)
EP (1) EP2928479A1 (cg-RX-API-DMAC10.html)
JP (1) JP2016501261A (cg-RX-API-DMAC10.html)
KR (1) KR20150093216A (cg-RX-API-DMAC10.html)
AU (1) AU2013356793A1 (cg-RX-API-DMAC10.html)
CA (1) CA2893973A1 (cg-RX-API-DMAC10.html)
IL (1) IL239144A0 (cg-RX-API-DMAC10.html)
PL (1) PL234888B1 (cg-RX-API-DMAC10.html)
WO (1) WO2014088435A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL234887B1 (pl) * 2012-12-06 2020-04-30 Univ Lodzki Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-DS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej
PL416636A1 (pl) * 2016-03-24 2017-09-25 Univ Łódzki Medyczne zastosowanie dendrymeru polipropylenoiminowego czwartej generacji, opłaszczonego maltotriozą

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090208580A1 (en) 2005-09-19 2009-08-20 Regents Of The University Of Michigan Functionalized dendrimer-encapsulated and dendrimer-stabilized nanoparticles
US20110177602A1 (en) * 2007-06-27 2011-07-21 Endress + Hauser Conducts Gesellschaft furMess-und Regeltechnik mbH +Co. KG Composite Structure
PL234887B1 (pl) * 2012-12-06 2020-04-30 Univ Lodzki Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-DS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej

Similar Documents

Publication Publication Date Title
JP2013527232A5 (cg-RX-API-DMAC10.html)
JP2011173928A5 (cg-RX-API-DMAC10.html)
JP2019524865A5 (cg-RX-API-DMAC10.html)
JP2013541583A5 (cg-RX-API-DMAC10.html)
FI3562486T3 (fi) Kielenalaisen deksmedetomidiinin käyttö agitaation hoidossa
JP2012526843A5 (cg-RX-API-DMAC10.html)
FI3125875T3 (fi) Inhaloitava rapamysiiniformulaatio ikäsidonnaisten tilojen hoitoon
JP2017512194A5 (cg-RX-API-DMAC10.html)
FI3435996T3 (fi) Elafibranori käytettäväksi primaarisen biliaarisen kolangiitin hoidossa
JP2017507142A5 (cg-RX-API-DMAC10.html)
AR085120A1 (es) Formulaciones de particulas en polvo seco que contienen dos o mas ingredientes activos para el tratamiento de las enfermedades obstructivas o inflamatorias de las vias respiratorias
JP2015519330A5 (cg-RX-API-DMAC10.html)
JP2015057451A5 (cg-RX-API-DMAC10.html)
JP2015083580A5 (cg-RX-API-DMAC10.html)
JP2016501865A5 (cg-RX-API-DMAC10.html)
JP2012503668A5 (cg-RX-API-DMAC10.html)
JP2012517987A5 (ja) 吸入用の医薬組成物のfpd特性を設定する方法
JP2015522630A5 (cg-RX-API-DMAC10.html)
JP2018537507A5 (cg-RX-API-DMAC10.html)
WO2015087258A8 (en) Modified-release therapeutic systems for oral administration of menthol in the treatment of intestinal disorders
JP2019531293A5 (cg-RX-API-DMAC10.html)
JP2018522028A5 (cg-RX-API-DMAC10.html)
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
JP2022532038A5 (cg-RX-API-DMAC10.html)
JP2016505050A5 (cg-RX-API-DMAC10.html)